These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12973143)

  • 1. Efficacy of autologous growth factors in lumbar intertransverse fusions.
    Weiner BK; Walker M
    Spine (Phila Pa 1976); 2003 Sep; 28(17):1968-70; discussion 1971. PubMed ID: 12973143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of Autologous Growth Factors (AGF) in lumbar interbody fusion.
    Jenis LG; Banco RJ; Kwon B
    Spine J; 2006; 6(1):14-20. PubMed ID: 16413442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of autologous growth factors in lumbar spinal fusion.
    Lowery GL; Kulkarni S; Pennisi AE
    Bone; 1999 Aug; 25(2 Suppl):47S-50S. PubMed ID: 10458274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions.
    Carreon LY; Glassman SD; Anekstein Y; Puno RM
    Spine (Phila Pa 1976); 2005 May; 30(9):E243-6; discussion E247. PubMed ID: 15864142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft.
    Neen D; Noyes D; Shaw M; Gwilym S; Fairlie N; Birch N
    Spine (Phila Pa 1976); 2006 Aug; 31(18):E636-40. PubMed ID: 16915079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of interconnected porous hydroxyapatite in achieving posterolateral lumbar fusion in sheep.
    Baramki HG; Steffen T; Lander P; Chang M; Marchesi D
    Spine (Phila Pa 1976); 2000 May; 25(9):1053-60. PubMed ID: 10788847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a collagen-hydroxyapatite matrix in spinal fusion. A rabbit model.
    Tay BK; Le AX; Heilman M; Lotz J; Bradford DS
    Spine (Phila Pa 1976); 1998 Nov; 23(21):2276-81. PubMed ID: 9820906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of an allogeneic bone matrix containing viable osteogenic cells in patients undergoing one- and two-level posterolateral lumbar arthrodesis with decompressive laminectomy.
    Musante DB; Firtha ME; Atkinson BL; Hahn R; Ryaby JT; Linovitz RJ
    J Orthop Surg Res; 2016 May; 11(1):63. PubMed ID: 27233773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
    Dai LY; Jiang LS
    Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of activated growth factors in lumbar spinal fusions.
    Castro FP
    J Spinal Disord Tech; 2004 Oct; 17(5):380-4. PubMed ID: 15385877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone graft gel: autologous growth factors used with autograft bone for lumbar spine fusions.
    Bose B; Balzarini MA
    Adv Ther; 2002; 19(4):170-5. PubMed ID: 12431042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model.
    Lehman RA; Dmitriev AE; Cardoso MJ; Helgeson MD; Christensen CL; Raymond JW; Eckel TT; Riew KD
    Spine (Phila Pa 1976); 2010 Jan; 35(2):146-52. PubMed ID: 20081509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do autologous growth factors enhance transforaminal lumbar interbody fusion?
    Hee HT; Majd ME; Holt RT; Myers L
    Eur Spine J; 2003 Aug; 12(4):400-7. PubMed ID: 12761669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intertransverse process lumbar arthrodesis with allogeneic fresh-frozen bone graft.
    Nugent PJ; Dawson EG
    Clin Orthop Relat Res; 1993 Feb; (287):107-11. PubMed ID: 8448926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and radiographic outcomes using local bone shavings as autograft in minimally invasive transforaminal lumbar interbody fusion.
    Kasliwal MK; Deutsch H
    World Neurosurg; 2012 Jul; 78(1-2):185-90. PubMed ID: 22120378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions.
    Kang J; An H; Hilibrand A; Yoon ST; Kavanagh E; Boden S
    Spine (Phila Pa 1976); 2012 May; 37(12):1083-91. PubMed ID: 22076647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.